A shortage of a human drug was reported by the FDA as a result of the coronavirus. The agency has been closely monitoring the supply chain in anticipation that the virus, dubbed COVID-19, would lead to potential drug shortages.
The FTC is moving to block a proposed merger between Jefferson Health and Einstein Healthcare Network, two Philadelphia-based health systems. The two entities have a combined annual revenue of $5.9 billion.
More than a dozen HHS workers sent to receive American evacuees from Wuhan, China––where the novel coronavirus originated––without proper training and protective gear, according to a whistleblower complaint reported by the Washington Post.